NextCure, Inc., 2025-12-10
An SEC Form D private-offering notice from Beltsville, MD, a $21,500,000 filer-stated offering target in Biotech. Filed 2025-12-10. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing immunomedicines and antibody drug conjugates to treat cancer.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Ferretly International, Inc., 2025-12-23, $1.5M, Easton, MD
- Invea Therapeutics, Inc, 2025-12-10, $120K, Guilford, CT
- PostCare, LLC, 2025-12-16, $1M, Ocean City, MD
- Verrica Pharmaceuticals Inc., 2025-12-10, $50M, West Chester, PA
- Cellphire, Inc., 2025-12-11, $3M, Rockville, MD
- BlossomHill Therapeutics, Inc., 2025-12-10, $84.2M, San Diego, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.